Veröffentlichungen | MDC Berlin

14 Ergebnisse:

Active Filter:

01. November 2006 in Eur J Immunol

Designer T cells by T cell receptor replacement

D. Sommermeyer
J. Neudorfer
M. Weinhold
M. Leisegang
B. Engels
E. Noessner
M.H. Heemskerk
J. Charo
D.J. Schendel
T. Blankenstein
H. Bernhard
W. Uckert

15. Mai 2006 in Cell Cycle

Reprogramming of B lymphoid cells in human lymphoma pathogenesis

M. Janz
B. Doerken
S. Mathas

01. April 2006 in Cell Death Differ

Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma

I. Sturm
C. Stephan
B. Gillissen
R. Siebert
M. Janz
S. Radetzki
K. Jung
S. Loening
B. Doerken
P.T. Daniel

15. März 2006 in Blood

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells

M. Janz
M. Hummel
M. Truss
B. Wollert-Wulf
S. Mathas
K. Joehrens
C. Hagemeier
K. Bommert
H. Stein
B. Doerken
R.C. Bargou

01. Februar 2006 in Nat Immunol

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

S. Mathas
M. Janz
F. Hummel
M. Hummel
B. Wollert-Wulf
S. Lusatis
I. Anagnostopoulos
A. Lietz
M. Sigvardsson
F. Jundt
K. Joehrens
K. Bommert
H. Stein
B. Doerken

25. August 2005 in Blood

Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas

S. Mathas
K. Joehrens
S. Joos
A. Lietz
F. Hummel
M. Janz
F. Jundt
I. Anagnostopoulos
K. Bommert
P. Lichter
H. Stein
C. Scheidereit
B. Doerken

01. Juli 2005 in Hum Gene Ther

Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes

B. Engels
E. Noessner
B. Frankenberger
T. Blankenstein
D.J. Schendel
W. Uckert

20. Mai 2005 in Bioforum

Gentherapie mit T-Zellrezeptor modifizierten Zellen

W. Uckert
T. Blankenstein

01. Januar 2005 in Blood

Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis

K.R. Koh
M. Janz
M.Y. Mapara
B. Lemke
D. Stirling
B. Doerken
M. Zenke
S. Lentzsch

01. Januar 2005 in Canc Res

CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells

T. Kammertoens
R. Willebrand
B. Erdmann
L. Li
Y. Li
B. Engels
W. Uckert
T. Blankenstein